Therapy of chronic viral hepatitis: the light at the end of the tunnel?
GM Saracco, A Marzano, M Rizzetto - Biomedicines, 2022 - mdpi.com
Chronic viral hepatitis determines significant morbidity and mortality globally and is caused
by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) …
by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) …
The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis
HY Hung, HH Lai, HC Lin, CY Chen - Annals of Medicine, 2023 - Taylor & Francis
Abstract Background The combination of Sofosbuvir (SOF), velpatasvir (VEL), and
voxilaprevir (VOX) is an effective, safe rescue therapy for patients with previous treatment …
voxilaprevir (VOX) is an effective, safe rescue therapy for patients with previous treatment …
Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C successfully treated with direct‐acting antiviral agents
A Ciancio, DG Ribaldone, A Dotta… - Liver …, 2021 - Wiley Online Library
Background and aims Clearance of hepatitis C virus (HCV) is associated with improved
glycometabolic control in patients with diabetes mellitus (DM) but whether this effect is …
glycometabolic control in patients with diabetes mellitus (DM) but whether this effect is …
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort)
T Barré, ML Nishimwe, C Protopopescu… - Journal of Viral …, 2020 - Wiley Online Library
Chronic hepatitis C virus (HCV) infection is a risk factor of insulin resistance, and HCV‐
infected patients are at a high risk of developing diabetes. In the general population …
infected patients are at a high risk of developing diabetes. In the general population …
Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
I Cacciola, G Russo, R Filomia, C Pitrone… - Liver …, 2021 - Wiley Online Library
Background Data concerning the impact of hepatitis C virus (HCV) cure on type 2 diabetes
mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti …
mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti …
The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV …
Virological responses after hepatitis C virus (HCV) treatment may alleviate liver disease and
extra-hepatic manifestations. Our study aims to explore the impact of HCV eradication on the …
extra-hepatic manifestations. Our study aims to explore the impact of HCV eradication on the …
[HTML][HTML] Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
II Salama, HM Raslan, GA Abdel-Latif… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a common cause of liver disease and is associated with various
extrahepatic manifestations (EHMs). This mini-review outlines the currently available …
extrahepatic manifestations (EHMs). This mini-review outlines the currently available …
Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review
A Cespiati, I Coelho Rodrigues, I Santos… - Liver …, 2024 - Wiley Online Library
Abstract Background and Aims The beneficial effect of Hepatitis C virus (HCV) eradication
by direct antiviral agents (DAAs) on liver fibrosis is well defined. Despite this, the impact of …
by direct antiviral agents (DAAs) on liver fibrosis is well defined. Despite this, the impact of …
[HTML][HTML] Direct antiviral agents in hepatitis C virus related liver disease: Don't count the chickens before they're hatched
S Compagnoni, EM Bruno, G Madonia… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Since molecules with direct-acting antiviral (DAA) became available, the landscape of the
treatment of hepatitis C virus (HCV) infection has completely changed. The new drugs are …
treatment of hepatitis C virus (HCV) infection has completely changed. The new drugs are …
The art of managing hepatitis C virus in special population groups: a paradigm shift
M Elbadry, AM Moussa, M Eltabbakh… - Egyptian Liver …, 2022 - Springer
The first direct-acting antiviral (DAA) medications were approved for the treatment of chronic
hepatitis C virus (HCV) in 2011. Later, the appearance of novel DAAs had revolutionized the …
hepatitis C virus (HCV) in 2011. Later, the appearance of novel DAAs had revolutionized the …